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sAdditional Supervised Exercise Therapy After a Percutaneous Vascular
Intervention for Peripheral Arterial Disease: A Randomized Clinical
Trial
Kruidenier LM, Nicola SP, Rouwet EV et al. J Vasc Interv Radiol 2011;22:
961-8.
Conclusion: Following a peripheral vascular intervention (PVI) super-
vised exercise training (SET) is more effective in increasing walking distance
than PVI alone.
Summary: TASC II suggests supervised exercise therapy (SET) is
primary treatment of intermittent claudication. However despite TASC
guidelines, percutaneous interventions (PVIs) are increasingly used for
treatment of intermittent claudication. Immediate technical success exceeds
90%. Many patients, however, after a PVI, and despite patency of the treated
arterial segment, have persistent or recurrent symptoms. It has been sug-
gested that SET combined with a PVI may provide better therapy than PVI
alone for patients with stable intermittent claudication (Mazari FA. Ann
Vasc Surg 2010;24:69-79).
The current study is a randomized prospective clinical trial evaluating
the combination of a PVI of either aortoiliac disease or infra-inguinal disease
in combination with supplemental SET. The combined patients were com-
pared to those undergoing a PVI alone. Patients with PAD treated with a
PVI were eligible for inclusion. Exclusion criteria were major amputation or
tissue loss, or any co-morbidity preventing physical activity, insufficient
knowledge of the Dutch language, no insurance for SET and prior partici-
pation in a SET program. All patients received a PVI and were then
randomly assigned to either PVI alone (n  35) or PVI plus SET (n  35).
The primary outcome parameter was absolute claudication distance. Quality
of life was assessed with the SF-36 and Europol 5-D questionnaires. Most
patients were treated for an aortoiliac lesion. Themean difference in absolute
claudication distance at 6 months of follow up was 271.3 meters (95% CI,
64-479; P  .011) in favor of the addition of SET to the PVI. In patients
treated with PVI alone, only one (3.7%) finished the complete treadmill test
compared with 11 (32.4%) treated with PVI and SET (P  .005). Physical
health related quality of life score was 44.1  7.8 in the intervention group
alone compared with 41.9  9.5 in the intervention plus exercise training
group, a non significant difference (P  .34) .
Comment: The study raises interesting questions about the role of
PVIs for treatment of claudication. One may ask what is it that matters, an
increase in walking distance or an increase in patient quality of life (QOL)? In
this study, an increase in walking distance did not translate directly into
QOL improvement for the patients. This suggests better selection methods
for treatment of patients with PVIs for claudication may be needed or that
perhaps the generic QOL instruments utilized here lacked sensitivity to
detect meaningful QOL changes in patients likely afflicted by numerous
additional co-morbidities. Different results may have been obtained with a
disease specific QOL instrument.
Staged Versus Synchronous Carotid Endarterectomy and Coronary
Artery Bypass Grafting: Analysis of 10-Year Nationwide Outcomes
Gopaldas RR, Chu D, Dao TK, et al. Ann Thorac Surg 2011;91:1323-9.
Conclusion: Patients undergoing staged or synchronous approaches
to carotid endarterectomy (CEA) and coronary artery bypass grafting
(CABG) have no significant differences with respect to mortality or neuro-
logic complications.
Summary: Vascular and cardiac surgeons often have to determine how
to appropriately time surgical procedures for concurrent carotid and coro-
nary artery disease. In patients with co-existing carotid and coronary artery
disease (CAD), where both are judged to be in need of surgical repair, there
are studies favoring both synchronous and staged approaches (Naylor R et
al. Eur J Vasc Endovasc Surg 2003;26:230-41, Takach TJ et al. Ann Thorac
Surg 1997;64:16-22, and Hertzer NR et al. J Vasc Surg 1989;9:455-63).
Vascular surgeons are concerned about potential cardiac complications in
their patients undergoing CEA who also have severe coronary artery disease,
but are also concerned about being “ credited “ for a stroke in patients
undergoing a synchronous CABG and CEA when the etiology of the stroke
may be related to the CABG rather than the CEA. Many institutions reserve
synchronous procedures for patients with severe coronary and cerebrovas-
cular symptoms. Some have found better outcomes in patients with asymp-
tomatic carotid disease, than in patients with carotid symptoms supporting
the use of synchronous CABG and CEA in patients with asymptomatic
carotid disease (Estes JM, et al. J Vasc Surg 2001;33:1179-84). The authors
sought to assess nationwide use of synchronous and staged approaches to s
1846EA and CABG. They also evaluated differences in costs and surgical
utcomes between the two operative approaches.
The nationwide inpatient sample data base from 1988 to 2007 was
tilized for this study. The authors identified 6153 patients who underwent
EA before or after CABG during the same hospital admission, but not on
he same day (Staged). There were 16,639 patients who underwent both
rocedures on the same day (Synchronous). Independent effects of opera-
ive strategy onmortality, neurologic and overall complications, and hospital
harges were determined with hierarchic multivariable regression analysis.
he mean age of the patients was 69.5  9.0 years. The Charlson-Deyo
core (4.6  1.5) was similar for both groups. Neurologic complications
.5% versus 3.9% and mortality 4.2 % versus 4.5% were similar between
roups (P  .7 for both). Staged patients had higher morbidity (48.4%
ersus 49.6%; OR, 1.8; 95%CI, 1.5 to 2.2; P  .001). Staged patients also
ad more cardiac (OR, 1.5; 95%CI, 1.4 to 1.7; P .001), wound (OR, 2.1;
5% CI, 1.8 to 2.4; P .001), respiratory (OR, 1.2; 95% CI, 1.1 to 1.3; P
001), and renal complications (OR, 1.2; 95% CI, 1.03 to 1.3; P  .001).
n-pump CABG increased stroke rates in synchronous patients (OR, 1.6;
5% CI, 1.3 to 1.9; P  .001). Hospital charges were higher in the staged
atients by $23,323 (P .001).
Comment: There continues to be no definitive answer to the question
f what to do with patients requiring both CEA and CABG in close
roximity to each other. This study seems to favor simultaneous procedures.
ospital chargers where higher with staged procedures and neurologic
omplications and mortality were not different. However, the exact severity
f the carotid or coronary disease is unknown in these patients. We do not
now what proportion of patients underwent a so called “staged procedure”
o treat a complication of the initial procedure. Patients who underwent
eparate, but temporarily close admissions, for CABG and CEA are not
dentified, but could, in effect, have undergone staged procedures. Finally,
n about ½ the patients data on dates of admission, operation or discharge
ere missing, thus preventing classifying operations as synchronous or
taged. The best that one can conclude from this article is that it does not
iscredit the practice of simultaneous CEA and CABG. However, it is also
ot strong evidence toward the performance of synchronous procedures.
lincial and Technical Outcomes From a Randomized Clinical Trial of
ndovenous Laser Ablation Compared With Conventional Surgery for
reat Saphenous Varicose Veins
arradice D, Mekako AI, Mazari FA, et al. Br J Surg 2011;98:117-23.
Conclusion: In the short term endovascular laser ablation (EVLA) has
ower rates of clinical recurrence than conventional surgery in treatment of
reat saphenous vein (GSV) varicose veins.
Summary: Conventional surgical treatment of superficial venous in-
ompetence has high recurrence rates; up to 30% at one year, 40% at two
ears and 66% beyond 10 years (Campbell WB et al. Ann R Coll Surg Engl
003;85:52-7, and Van Rij AM et al. J Vasc Surg 2003;38:935-43).
equests for intervention following recurrence are less common than recur-
ence of varicosities. About 15 to 20% of varicose vein procedures are
erformed for recurrence (Gibbs PJ et al. Eur J Vasc Endovasc Surg
999;18:494-8). This paper reports relative rates of clinical recurrence and
atterns of treatment failure of patients enrolled in a non-blinded, random-
zed trial of endovenous laser ablation (EVLA) versus conventional surgery
n treatment of GSV varicose veins. There were 280 patients randomized
qually using sealed opaque envelopes to two parallel groups, EVLA or
onventional surgery. To be included in the trial, patients had to have
ymptomatic disease secondary to primary unilateral isolated saphenofemo-
al junction incompetence leading to GSV reflux. Outcomes analyzed were
echnical success, recurrent veins on clinical examination, patterns of reflux
n duplex ultrasound examination, and effect of recurrence on quality of life
s assessed by the Aberdeen Varicose Vein Questionnaire (AVVQ). Assess-
ents were performed at 1, 6, 12 and 52 weeks.
Technical success was better with EVLA than conventional surgery
99.3 vs 92.4%; P  .005). Inability to strip the above knee GSV was the
ain cause of surgical failure. Clinical recurrence at 1 year was lower after
VLA (4% vs 20.4 %; P .001). It is estimated that 6.3 patients would need
o be treated with EVLA rather than surgery to avoid one recurrence at one
ear (95% CI, 4.0 to 12.5). Of the 23 surgical recurrences, 12 were related
o incompetent below the knee GSVs and 10 were ascribed to neovascular-
ztion. There were 5 recurrences following EVLA with two related to
eoreflux and groin tributaries and one to recanalization. Worse AVVQ
cores correlated with clinical recurrence (P  .001).Comment: One can question the widely practiced principal of only
tripping the GSV to the knee as the largest number of recurrences in the
